50 related articles for article (PubMed ID: 2958026)
1. Comparison of the accumulation kinetics of L-(methyl-11C)-methionine and D-(methyl-11C)-methionine in brain tumors studied with positron emission tomography.
Bergström M; Lundqvist H; Ericson K; Lilja A; Johnström P; Långström B; von Holst H; Eriksson L; Blomqvist G
Acta Radiol; 1987; 28(3):225-9. PubMed ID: 2958026
[TBL] [Abstract][Full Text] [Related]
2. Differential diagnosis of AH109A tumor and inflammation by radioscintigraphy with L-[methyl-11C]methionine.
Kubota K; Matsuzawa T; Fujiwara T; Sato T; Tada M; Ido T; Ishiwata K
Jpn J Cancer Res; 1989 Aug; 80(8):778-82. PubMed ID: 2511187
[TBL] [Abstract][Full Text] [Related]
3. Development of an Imaging Technique for Boron Neutron Capture Therapy.
Fukumitsu N; Matsumoto Y
Cells; 2021 Aug; 10(8):. PubMed ID: 34440904
[TBL] [Abstract][Full Text] [Related]
4. Ventricle contact may be associated with higher 11C methionine PET uptake in glioblastoma.
van Dijken BRJ; Schuuring B; Jeltema HR; van Laar PJ; Enting RH; Dierckx RAJO; Stormezand GN; van der Hoorn A
Neuroradiology; 2022 Feb; 64(2):247-252. PubMed ID: 34114063
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Tumor Volume Response Assessment Using (11)C-Methionine Positron Emission Tomography Identifies Glioblastoma Tumor Subregions That Predict Progression Better Than Baseline or Anatomic Magnetic Resonance Imaging Alone.
Miller S; Li P; Schipper M; Junck L; Piert M; Lawrence TS; Tsien C; Cao Y; Kim MM
Adv Radiat Oncol; 2020; 5(1):53-61. PubMed ID: 32051890
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic image-based histological analysis reveals a correlation between
Okita Y; Shofuda T; Kanematsu D; Yoshioka E; Kodama Y; Mano M; Kinoshita M; Nonaka M; Nakajima S; Fujinaka T; Kanemura Y
Oncol Lett; 2018 Aug; 16(2):1924-1930. PubMed ID: 30008885
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of D-isomers of 4-borono-2-
Kanazawa M; Nishiyama S; Hashimoto F; Kakiuchi T; Tsukada H
EJNMMI Res; 2018 Jun; 8(1):47. PubMed ID: 29900520
[TBL] [Abstract][Full Text] [Related]
8. Glioma grading by dynamic susceptibility contrast perfusion and
Brendle C; Hempel JM; Schittenhelm J; Skardelly M; Reischl G; Bender B; Ernemann U; la Fougère C; Klose U
Neuroradiology; 2018 Apr; 60(4):381-389. PubMed ID: 29464269
[TBL] [Abstract][Full Text] [Related]
9. Relationship between the uptake of
Watanabe Y; Kurihara H; Itami J; Sasaki R; Arai Y; Sugimura K
Radiat Oncol; 2017 Jan; 12(1):17. PubMed ID: 28088230
[TBL] [Abstract][Full Text] [Related]
10. The Potential of Metabolic Imaging.
Di Gialleonardo V; Wilson DM; Keshari KR
Semin Nucl Med; 2016 Jan; 46(1):28-39. PubMed ID: 26687855
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and Prognostic Value of 11C-Methionine PET for Nonenhancing Gliomas.
Takano K; Kinoshita M; Arita H; Okita Y; Chiba Y; Kagawa N; Fujimoto Y; Kishima H; Kanemura Y; Nonaka M; Nakajima S; Shimosegawa E; Hatazawa J; Hashimoto N; Yoshimine T
AJNR Am J Neuroradiol; 2016 Jan; 37(1):44-50. PubMed ID: 26381556
[TBL] [Abstract][Full Text] [Related]
12. Value of 11C-methionine PET in imaging brain tumours and metastases.
Glaudemans AW; Enting RH; Heesters MA; Dierckx RA; van Rheenen RW; Walenkamp AM; Slart RH
Eur J Nucl Med Mol Imaging; 2013 Apr; 40(4):615-35. PubMed ID: 23232505
[TBL] [Abstract][Full Text] [Related]
13. Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications.
Waerzeggers Y; Ullrich RT; Monfared P; Viel T; Weckesser M; Stummer W; Schober O; Winkeler A; Jacobs AH
Br J Radiol; 2011 Dec; 84 Spec No 2(Spec Iss 2):S179-95. PubMed ID: 22433828
[TBL] [Abstract][Full Text] [Related]
14. The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade II.
Smits A; Baumert BG
Int J Mol Imaging; 2011; 2011():372509. PubMed ID: 21603237
[TBL] [Abstract][Full Text] [Related]
15. Contributions of biological tumor parameters to the incorporation rate of L: -[methyl-(11)C] methionine into astrocytomas and oligodendrogliomas.
Nojiri T; Nariai T; Aoyagi M; Senda M; Ishii K; Ishiwata K; Ohno K
J Neurooncol; 2009 Jun; 93(2):233-41. PubMed ID: 19099197
[TBL] [Abstract][Full Text] [Related]
16. Adding 11C-methionine PET to the EORTC prognostic factors in grade 2 gliomas.
Smits A; Westerberg E; Ribom D
Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):65-71. PubMed ID: 17710394
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of D-isomers of O-18F-fluoromethyl, O-18F-fluoroethyl and O-18F-fluoropropyl tyrosine as tumour imaging agents in mice.
Tsukada H; Sato K; Fukumoto D; Kakiuchi T
Eur J Nucl Med Mol Imaging; 2006 Sep; 33(9):1017-24. PubMed ID: 16699766
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of 11C-methionine PET as a surrogate endpoint after treatment of grade 2 gliomas.
Ribom D; Schoenmaekers M; Engler H; Smits A
J Neurooncol; 2005 Feb; 71(3):325-32. PubMed ID: 15735925
[TBL] [Abstract][Full Text] [Related]
19. Proliferation-dependent changes in amino acid transport and glucose metabolism in glioma cell lines.
Sasajima T; Miyagawa T; Oku T; Gelovani JG; Finn R; Blasberg R
Eur J Nucl Med Mol Imaging; 2004 Sep; 31(9):1244-56. PubMed ID: 15141325
[TBL] [Abstract][Full Text] [Related]
20. Methyl-[11C]- l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma.
Kracht LW; Friese M; Herholz K; Schroeder R; Bauer B; Jacobs A; Heiss WD
Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):868-73. PubMed ID: 12692687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
